NASDAQ:INGN

Inogen (INGN) Stock Price, News & Analysis

Inogen logo
$5.30 -0.12 (-2.12%)
Closing price 03:59 PM Eastern
Extended Trading
$5.30 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Inogen Stock (NASDAQ:INGN)

Advanced

Key Stats

Today's Range
$5.24
▼
$5.70
50-Day Range
$5.09
▼
$7.26
52-Week Range
$5.05
▼
$7.67
Volume
274,675 shs
Average Volume
296,006 shs
Market Capitalization
$137.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Inogen, Inc. is a medical technology company focused on respiratory care. It develops, manufactures and markets oxygen concentrators and related products for people who require supplemental oxygen, including those with chronic respiratory conditions.

Its products include the Inogen One line of portable oxygen concentrators, stationary oxygen concentrators and accessories. The company sells through direct-to-consumer channels and healthcare providers.

Founded in 2001 and headquartered in Goleta, California, Inogen serves customers in the United States and international markets.

AI Generated. May Contain Errors.

Inogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

INGN MarketRank™: 
0.950486901655 of 5 stars

Inogen scored higher than 19% of companies evaluated by MarketBeat, and ranked 801st out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inogen has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Inogen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Inogen's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Inogen is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Inogen is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Inogen has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.42% of the float of Inogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Inogen has a short interest ratio ("days to cover") of 5.76.
  • Change versus previous month

    Short interest in Inogen has recently decreased by 8.34%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Inogen does not currently pay a dividend.

  • Dividend Growth

    Inogen does not have a long track record of dividend growth.

  • News Sentiment

    Inogen has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Inogen this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Inogen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Inogen is held by insiders.

  • Percentage Held by Institutions

    89.94% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Inogen's insider trading history.
Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INGN Stock News Headlines

Inogen Announces Executive Departure and Board Resignation
Inogen (NASDAQ:INGN) Rating Lowered to Sell at Wall Street Zen
A Bill Would Reprice America's Gold at Market Value
The US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,000 today, leaving a trillion-dollar gap on the books. A bill now moving through Congress would require the Treasury to reprice America's gold at true market value. Companion legislation would trigger the first full audit of US reserves in over 65 years.tc pixel
Inogen, Inc. (INGN) Q3 2026 Earnings Call Transcript
Inogen Stock Drops 14% As Q3 Loss Triples
Inogen (INGN) Q3 2026 Earnings Call Transcript
See More Headlines

INGN Stock Analysis - Frequently Asked Questions

Inogen's stock was trading at $6.72 on January 1st, 2026. Since then, INGN shares have decreased by 21.1% and is now trading at $5.3050.

Inogen, Inc (NASDAQ:INGN) posted its quarterly earnings results on Thursday, November, 5th. The medical technology company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by $0.42. The medical technology company earned $77.19 million during the quarter, compared to analysts' expectations of $92.25 million. Inogen had a negative net margin of 10.46% and a negative trailing twelve-month return on equity of 19.29%.
Read the conference call transcript
.

Inogen (INGN) raised $75 million in an initial public offering (IPO) on Friday, February 14th 2014. The company issued 4,411,763 shares at a price of $16.00-$18.00 per share.

Inogen's top institutional investors include State Street Corp (2.28%), Goldman Sachs Group Inc. (2.15%), CSM Advisors LLC (1.46%) and Readystate Asset Management LP (0.95%). Insiders that own company stock include Boyer Jennifer M Yi and Jason Somer.
View institutional ownership trends
.

Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inogen investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), Tesla (TSLA), Shopify (SHOP), Block (XYZ) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/05/2026
Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:INGN
CIK
1294133
Fax
N/A
Employees
753
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($1.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.75 million
Net Margins
-10.46%
Pretax Margin
-10.67%
Return on Equity
-19.29%
Return on Assets
-12.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.96
Quick Ratio
2.55

Sales & Book Value

Annual Sales
$348.67 million
Price / Sales
0.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.04 per share
Price / Book
0.88

Miscellaneous

Outstanding Shares
26,000,000
Free Float
25,352,000
Market Cap
$137.54 million
Optionable
Optionable
Beta
1.51

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:INGN) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners